Triple
T23417439
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Bristol Myers Squibb |
E560549
|
entity |
| Predicate | formedByMergerOf |
P77
|
FINISHED |
| Object | Squibb Corporation |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Squibb Corporation | Statement: [Bristol Myers Squibb, formedByMergerOf, Squibb Corporation]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Squibb Corporation Context triple: [Bristol Myers Squibb, formedByMergerOf, Squibb Corporation]
-
A.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
B.
Schering-Plough
Schering-Plough was a major American pharmaceutical company known for developing prescription medicines, vaccines, and consumer health products before its merger with Merck & Co.
-
C.
Burroughs Wellcome Company
Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
-
D.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
E.
Warner-Lambert Company
Warner-Lambert Company was a major American pharmaceutical and consumer healthcare corporation best known for products like Listerine and for its acquisition by Pfizer in 2000.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Squibb Corporation Target entity description: Squibb Corporation was a major American pharmaceutical company that became part of Bristol Myers Squibb following a landmark merger in the late 20th century.
-
A.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
B.
Schering-Plough
Schering-Plough was a major American pharmaceutical company known for developing prescription medicines, vaccines, and consumer health products before its merger with Merck & Co.
-
C.
Burroughs Wellcome Company
Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
-
D.
Bristol Myers Squibb
chosen
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
E.
Warner-Lambert Company
Warner-Lambert Company was a major American pharmaceutical and consumer healthcare corporation best known for products like Listerine and for its acquisition by Pfizer in 2000.
- F. None of above.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454cb1108190ab21ada5411a7146 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1a516d158819081e9710b4e372a21 |
completed | April 29, 2026, 6:28 a.m. |
Created at: April 17, 2026, 5:39 p.m.